← All stocks

ADMA BIOLOGICS, INC.

ADMA Net buying

CIK 0001368514 #1977 in the set updated 18 Sep 2026

Bought (12 mo)

$468.29K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.90M

$0.00 on a plan · $1.90M straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

−$1.43M

+$468.29K against sales at will

By person

10 insiders · 17 transactions

18.0×

Adam S. Grossman holds 18.0 times base salary in stock. $16.71M of shares against $925.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam S. Grossman last reported holding, valued at $7.91, the price Common Stock was last bought or sold at on the open market here, on 27 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Grossman Adam S

President and CEO

—

$1.74M (10) scheduled

−$1.74M

2,112,777

0.9433%

$16.71M

+2.6%

Grossman Jerrold B

Director

$250.87K (3)

—

+$250.87K

520,284

0.2323%

$4.12M

+11.3%

ELMS STEVE

Director

$217.42K (2)

—

+$217.42K

2,143,750

0.9571%

$16.96M

−2.2%

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

—

$157.80K (1) scheduled

−$157.80K

443,061

0.1978%

$3.50M

−1.3%

KWON YOUNG

Director

—

263,020

0.1174%

$2.08M

−0.1%

Tade Brad L.

CFO and Treasurer

—

232,940

0.1040%

$1.84M

+8.6%

Kohler Terry

CFO and Treasurer

—

143,149

0.0639%

$1.13M

+146.7%

Guiheen Lawrence P.

Director

—

135,520

0.0605%

$1.07M

+30.4%

FINGER ALISON CECILY

Director

—

45,619

0.0204%

$360.85K

+89.8%

Salas Eduardo Rene

Director

—

21,579

0.0096%

$170.69K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 27

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 11

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,007,867

History held since 16 Feb 2017